Dmitry B. Veprintsev

9.5k total citations
108 papers, 7.3k citations indexed

About

Dmitry B. Veprintsev is a scholar working on Molecular Biology, Oncology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Dmitry B. Veprintsev has authored 108 papers receiving a total of 7.3k indexed citations (citations by other indexed papers that have themselves been cited), including 91 papers in Molecular Biology, 30 papers in Oncology and 23 papers in Cellular and Molecular Neuroscience. Recurrent topics in Dmitry B. Veprintsev's work include Receptor Mechanisms and Signaling (29 papers), Cancer-related Molecular Pathways (28 papers) and RNA modifications and cancer (17 papers). Dmitry B. Veprintsev is often cited by papers focused on Receptor Mechanisms and Signaling (29 papers), Cancer-related Molecular Pathways (28 papers) and RNA modifications and cancer (17 papers). Dmitry B. Veprintsev collaborates with scholars based in United Kingdom, Switzerland and United States. Dmitry B. Veprintsev's co-authors include Alan R. Fersht, Stefan M.V. Freund, Andreas C. Joerger, Richard L. Weinberg, Roger Williams, Assaf Friedler, María Rosario Fernández‐Fernández, M. Madan Babu, Franziska M. Heydenreich and Stefan Rüdiger and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Dmitry B. Veprintsev

105 papers receiving 7.2k citations

Peers

Countries citing papers authored by Dmitry B. Veprintsev

Since Specialization

Citations

This map shows the geographic impact of Dmitry B. Veprintsev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dmitry B. Veprintsev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dmitry B. Veprintsev more than expected).

Fields of papers citing papers by Dmitry B. Veprintsev

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dmitry B. Veprintsev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dmitry B. Veprintsev. The network helps show where Dmitry B. Veprintsev may publish in the future.

Co-authorship network of co-authors of Dmitry B. Veprintsev

This figure shows the co-authorship network connecting the top 25 collaborators of Dmitry B. Veprintsev. A scholar is included among the top collaborators of Dmitry B. Veprintsev based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dmitry B. Veprintsev. Dmitry B. Veprintsev is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Multiple intramolecular triggers converge to preferential G protein coupling in the CB2R 2025 ·Nature Communications ·(unknown), Tamara Miljuš, (unknown), Tomasz Maciej Stępniewski, (unknown), Franziska M. Heydenreich, Tilman Flock, Bianca Plouffe, Christian Le Gouill, Jean Duchaine, David A. Sykes, (unknown), Eline J. Koers, Wolfgang Guba, Arne C. Rufer, Uwe Grether, Michel Bouvier, Dmitry B. Veprintsev, Jana Selent	1
2	Biased Signaling and Its Role in the Genesis of Short- and Long-Acting β₂-Adrenoceptor Agonists 2025 ·Biochemistry ·(unknown), (unknown), (unknown), (unknown), Nori Geary, Wolfgang Guba, Yuan‐Ping Han, (unknown), Eline J. Koers, Arne C. Rufer, Uwe Grether, Dmitry B. Veprintsev, David A. Sykes	0
3	Structural basis of THC analog activity at the Cannabinoid 1 receptor 2025 ·Nature Communications ·Thor S. Thorsen, Yashraj Kulkarni, David A. Sykes, Andreas Bøggild, (unknown), (unknown), Christos Iliopoulos‐Tsoutsouvas, Spyros P. Nikas, Henrik Daver, Alexandros Makriyannis, Poul Nissen, Michael Gajhede, Dmitry B. Veprintsev, Thomas Boesen, J.S. Kastrup, David E. Gloriam	5
4	Flipping the GPCR Switch: Structure-Based Development of Selective Cannabinoid Receptor 2 Inverse Agonists 2024 ·ACS Central Science ·(unknown), Roman C. Sarott, David A. Sykes, (unknown), Rosa Maria Vitale, (unknown), Xiaoting Li, (unknown), (unknown), (unknown), (unknown), (unknown), Wolfgang Guba, Peter J. McCormick, Tian Hua, Christian W. Gruber, Dmitry B. Veprintsev, James A. Frank, Uwe Grether, Erick M. Carreira	9
5	Mechano-sensitivity of β2-adrenoceptors enhances constitutive activation of cAMP generation that is inhibited by inverse agonists 2024 ·Communications Biology ·(unknown), (unknown), (unknown), (unknown), (unknown), Mark Soave, Dmitry B. Veprintsev, Jeanette Woolard, Laura E. Kilpatrick, Stephen J. Hill	0
6	Molecular recognition of an odorant by the murine trace amine-associated receptor TAAR7f 2024 ·Nature Communications ·Anastasiia Gusach, Yang Lee, (unknown), (unknown), Ning Ma, Eline J. Koers, (unknown), Patricia C. Edwards, Fanglu Huang, Jonathan Kim, Filippo Mancia, Dmitry B. Veprintsev, Nagarajan Vaidehi, (unknown), Christopher G. Tate	3
7	Development of a membrane-based Gi-CASE biosensor assay for profiling compounds at cannabinoid receptors 2023 ·Frontiers in Pharmacology ·(unknown), (unknown), (unknown), (unknown), (unknown), Wolfgang Guba, Arne C. Rufer, Uwe Grether, Dmitry B. Veprintsev, David A. Sykes	2
8	Platform Reagents Enable Synthesis of Ligand-Directed Covalent Probes: Study of Cannabinoid Receptor 2 in Live Cells 2023 ·Journal of the American Chemical Society ·(unknown), David A. Sykes, (unknown), Rosa Maria Vitale, Roman C. Sarott, (unknown), David Onion, (unknown), Philipp Leippe, Christoph Ullmer, (unknown), Wolfgang Guba, Uwe Grether, James A. Frank, Dmitry B. Veprintsev, Erick M. Carreira	20
9	ThermoBRET: A Ligand‐Engagement Nanoscale Thermostability Assay Applied to GPCRs** 2023 ·ChemBioChem ·(unknown), (unknown), Amandeep Kaur, (unknown), Tamara Miljuš, Eline J. Koers, (unknown), (unknown), Nicholas D. Holliday, David A. Sykes, Dmitry B. Veprintsev	0
10	Combined docking and machine learning identify key molecular determinants of ligand pharmacological activity on β2 adrenoceptor 2022 ·Pharmacology Research & Perspectives ·Mireia Jiménez‐Rosés, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Eline J. Koers, David A. Sykes, Iain B. Styles, Dmitry B. Veprintsev	12
11	Kinetic analysis of endogenous β₂‐adrenoceptor‐mediated cAMP GloSensor™ responses in HEK293 cells 2022 ·British Journal of Pharmacology ·(unknown), Dmitry B. Veprintsev, Stephen J. Hill	6
12	Exploring the kinetic selectivity of drugs targeting the β ₁ ‐adrenoceptor 2022 ·Pharmacology Research & Perspectives ·David A. Sykes, Mireia Jiménez‐Rosés, John Reilly, Robin A. Fairhurst, Steven J. Charlton, Dmitry B. Veprintsev	6
13	Ligand-directed covalent labelling of a GPCR with a fluorescent tag in live cells 2020 ·Communications Biology ·Leigh A. Stoddart, Nicholas D. Kindon, (unknown), (unknown), (unknown), Dmitry B. Veprintsev, Jeanette Woolard, Stephen J. Briddon, Hester Franks, Stephen J. Hill, Barrie Kellam	28
14	Distinct G protein-coupled receptor phosphorylation motifs modulate arrestin affinity and activation and global conformation 2019 ·Nature Communications ·Daniel Mayer, Fred F. Damberger, (unknown), (unknown), Ziva Vuckovic, Tilman Flock, (unknown), Eshita Mutt, Franziska Zosel, Frédéric H.‐T. Allain, Jörg Standfuss, Gebhard F. X. Schertler, Xavier Deupí, M. Sommer, Mattan Hurevich, Assaf Friedler, Dmitry B. Veprintsev	81
15	Universal allosteric mechanism for Gα activation by GPCRs 2015 ·Nature ·Tilman Flock, Charles N. J. Ravarani, Dawei Sun, AJ Venkatakrishnan, Melis Kayikci, Christopher G. Tate, Dmitry B. Veprintsev, M. Madan Babu	277
16	Structures of SAS-6 Suggest Its Organization in Centrioles 2011 ·Science ·M. van Breugel, Masafumi Hirono, Antonina Andreeva, Haruaki Yanagisawa, Shoko Yamaguchi, Yuki Nakazawa, Nina Morgner, Miriana Petrovich, Ima-Obong Ebong, Carol V. Robinson, Christopher M. Johnson, Dmitry B. Veprintsev, Benoît Zuber	251
17	Targeted rescue of a destabilized mutant of p53 by an in silico screened drug 2008 ·Proceedings of the National Academy of Sciences ·Frank M. Boeckler, Andreas C. Joerger, (unknown), Trevor J. Rutherford, Dmitry B. Veprintsev, Alan R. Fersht	304
18	Core domain interactions in full-length p53 in solution 2006 ·Proceedings of the National Academy of Sciences ·Dmitry B. Veprintsev, Stefan M.V. Freund, Antonina Andreeva, (unknown), Henning Tidow, José Manuel Pérez‐Cañadillas, (unknown), Alan R. Fersht	86
19	A peptide that binds and stabilizes p53 core domain: Chaperone strategy for rescue of oncogenic mutants 2002 ·Proceedings of the National Academy of Sciences ·Assaf Friedler, Lars O. Hansson, Dmitry B. Veprintsev, Stefan M.V. Freund, (unknown), Penka V. Nikolova, Mark R. Proctor, Stefan Rüdiger, Alan R. Fersht	217
20	Interactions of alpha-lactalbumins with lipid vesicles studied by tryptophan fluorescence. 1996 ·Lithuanian University of Health Sciences ·(unknown), Lina P. Kalinichenko, Gintaras Deikus, Dmitry B. Veprintsev, Kevin M. Cawthern, L.J. Berliner, (unknown)	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact